Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 7:30 PM View:  | Baranick Brian EVP, GM., Precision Oncology | EXACT Sciences Corp. (EXAS) | 02-Apr-24 | Market Sale (Planned) | 924 | $79.43 | $73,393.30 | (6%) 14.55K to 13.63K | 6% |
| 03-Apr-24 7:30 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Apr-24 | Market Sale (Planned) | 2,000 | $70.00 | $140,000.00 | (3%) 79.51K to 77.51K | (6%) |
| 01-Apr-24 4:30 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 28-Mar-24 | Market Sale (Planned) | 2,000 | $70.00 | $140,000.00 | (2%) 81.51K to 79.51K | (6%) |
| 04-Mar-24 8:36 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,323 | $59.32 | $137,800.00 | (14%) 16.87K to 14.55K | |
| 04-Mar-24 8:42 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,154 | $59.32 | $127,775.00 | (12%) 17.59K to 15.44K | |
| 04-Mar-24 8:39 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Sale (Planned) | 2,000 | $57.50 | $115,000.00 | (4%) 52.11K to 50.11K | |
| 04-Mar-24 8:37 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 1,724 | $59.32 | $102,268.00 | (2%) 83.24K to 81.51K | |
| 04-Mar-24 8:42 PM View: | Levangie Daniel J Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Sale (Planned) | 5,000 | $57.50 | $287,500.00 | (18%) 27.98K to 22.98K | |
| 04-Mar-24 8:41 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 862 | $59.32 | $51,133.80 | (8%) 11.17K to 10.31K | |
| 04-Mar-24 8:40 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,412 | $59.32 | $143,080.00 | (16%) 14.93K to 12.52K | |
| 04-Mar-24 8:38 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,412 | $59.32 | $143,080.00 | (5%) 49.16K to 46.75K | |
| 04-Mar-24 8:38 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 8,271 | $59.32 | $490,636.00 | (< 1%) 1.36M to 1.35M | |
| 04-Mar-24 8:41 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 1,890 | -- | -- | 20% 9.28K to 11.17K | |
| 04-Mar-24 8:40 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 5,291 | -- | -- | 55% 9.64K to 14.93K | |
| 04-Mar-24 8:38 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 18,143 | -- | -- | 1% 1.34M to 1.36M | |
| 04-Mar-24 8:37 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 3,779 | -- | -- | 5% 79.46K to 83.24K | |
| 04-Mar-24 8:42 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 4,724 | -- | -- | 37% 12.87K to 17.59K | |
| 04-Mar-24 8:38 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 5,291 | -- | -- | 12% 43.87K to 49.16K | |
| 04-Mar-24 8:36 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 4,724 | -- | -- | 39% 12.15K to 16.87K | |
| 28-Feb-24 7:35 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 1,880 | $56.89 | $106,953.00 | (2%) 81.34K to 79.46K | |
| 28-Feb-24 7:38 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 784 | $56.89 | $44,601.80 | (8%) 10.06K to 9.28K | |
| 28-Feb-24 7:36 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 2,710 | $56.89 | $154,172.00 | (22%) 12.35K to 9.64K | |
| 28-Feb-24 7:37 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 3,648 | $56.89 | $207,535.00 | (8%) 47.52K to 43.87K | |
| 28-Feb-24 7:35 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 6,263 | $56.89 | $356,302.00 | (< 1%) 1.35M to 1.34M | |
| 28-Feb-24 7:34 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 2,027 | $56.89 | $115,316.00 | (14%) 14.18K to 12.15K | |
| 28-Feb-24 7:38 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 1,879 | $56.89 | $106,896.00 | (13%) 14.75K to 12.87K | |
| 28-Feb-24 7:35 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 3,954 | -- | -- | 5% 77.38K to 81.34K | |
| 28-Feb-24 7:38 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 3,954 | -- | -- | 37% 10.8K to 14.75K | |
| 28-Feb-24 7:37 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 7,678 | -- | -- | 19% 39.84K to 47.52K | |
| 28-Feb-24 7:34 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 3,954 | -- | -- | 39% 10.22K to 14.18K | |
| 28-Feb-24 7:38 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 1,648 | -- | -- | 20% 8.42K to 10.06K | |
| 28-Feb-24 7:36 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 5,701 | -- | -- | 86% 6.65K to 12.35K | |
| 28-Feb-24 7:35 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 13,181 | -- | -- | < 1% 1.33M to 1.35M | |
| 26-Feb-24 5:00 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 23-Feb-24 | Payment of Exercise | 61,560 | $57.53 | $3,541,550.00 | (4%) 1.39M to 1.33M | |
| 26-Feb-24 5:00 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 23-Feb-24 | Option Exercise | 102,837 | $13.96 | $1,435,600.00 | 8% 1.29M to 1.39M | |
| 26-Feb-24 5:00 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 23-Feb-24 | Sale (Planned) | 1,021 | $59.72 | $60,974.10 | (1%) 78.41K to 77.38K | |
| 23-Feb-24 8:02 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 291 | $59.78 | $17,396.00 | (3%) 8.71K to 8.42K | |
| 23-Feb-24 8:01 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 1,351 | $59.78 | $80,762.80 | (17%) 8.0K to 6.65K | |
| 23-Feb-24 8:00 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 1,350 | $59.78 | $80,703.00 | (3%) 41.19K to 39.84K | |
| 23-Feb-24 7:59 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 11,565 | $59.78 | $691,356.00 | (< 1%) 1.3M to 1.29M | |
| 23-Feb-24 7:59 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 663 | $59.78 | $39,634.10 | (1%) 49.85K to 49.19K | |
| 23-Feb-24 7:57 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 1,013 | $59.78 | $60,557.10 | (1%) 79.42K to 78.41K | |
| 23-Feb-24 7:57 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 1,093 | $59.78 | $65,339.50 | (10%) 11.31K to 10.22K | |
| 23-Feb-24 8:03 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 1,013 | $59.78 | $60,557.10 | (9%) 11.81K to 10.8K | |
| 22-Feb-24 7:38 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Planned Option Sale | 706 | $61.50 | $43,419.00 | (1%) 48.52K to 47.82K | |
| 23-Feb-24 7:57 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Grant | 2,034 | -- | -- | 3% 77.38K to 79.42K | |
| 23-Feb-24 7:59 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Grant | 23,238 | -- | -- | 2% 1.28M to 1.3M | |
| 23-Feb-24 8:00 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Grant | 2,711 | -- | -- | 7% 38.48K to 41.19K | |
| 22-Feb-24 7:36 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Planned Option Sale | 1,079 | $61.50 | $66,358.50 | (1%) 78.46K to 77.38K | |
| 22-Feb-24 7:36 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Planned Option Sale | 895 | $61.50 | $55,042.50 | (9%) 10.18K to 9.28K |
